6U5Y
Discovery and optimization of salicyclic acid-derived sulfonamide inhibitors of the WDR5:MYC protein-protein interaction
Summary for 6U5Y
Entry DOI | 10.2210/pdb6u5y/pdb |
Descriptor | WD repeat-containing protein 5, 3-{[(5-bromo-3-chloro-2-hydroxyphenyl)sulfonyl]amino}-5-(1-cyanocyclobutyl)-2-hydroxy-N-methylbenzamide (3 entities in total) |
Functional Keywords | wdr5, myc, rbbp5, structure-based design, high-throughput screening, transcription |
Biological source | Homo sapiens (Human) |
Total number of polymer chains | 2 |
Total formula weight | 68013.59 |
Authors | |
Primary citation | Macdonald, J.D.,Chacon Simon, S.,Han, C.,Wang, F.,Shaw, J.G.,Howes, J.E.,Sai, J.,Yuh, J.P.,Camper, D.,Alicie, B.M.,Alvarado, J.,Nikhar, S.,Payne, W.,Aho, E.R.,Bauer, J.A.,Zhao, B.,Phan, J.,Thomas, L.R.,Rossanese, O.W.,Tansey, W.P.,Waterson, A.G.,Stauffer, S.R.,Fesik, S.W. Discovery and Optimization of Salicylic Acid-Derived Sulfonamide Inhibitors of the WD Repeat-Containing Protein 5-MYC Protein-Protein Interaction. J.Med.Chem., 62:11232-11259, 2019 Cited by PubMed: 31724864DOI: 10.1021/acs.jmedchem.9b01411 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.532 Å) |
Structure validation
Download full validation report